Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Transfus Apher Sci. 2020 Oct;59(5):102944. doi: 10.1016/j.transci.2020.102944. Epub 2020 Sep 17.
As an East-Asian international study, we evaluated erythrocyte alloimmunity by gender and history of transfusion or pregnancy. In total, data from more than 1,826,000 patients were analyzed, from whom 26,170 irregular erythrocyte antibodies were detected in 22,653 cases. Antibody frequencies in these cases were as follows: anti-E, 26.8%; anti-Le, 20.0%; anti-P1, 7.1%; anti-M, 6.4%; anti-Mi, 5.6%; anti-c + E, 5.6%; anti-Le, 4.6%; anti-D, 2.8%; anti-Fy, 2.6%; anti-Le+Le, 2.5%; anti-Di, 2.0%; and others. For pregnant patients, anti-D (12.7%) was statistically more frequent. For transfused patients, anti-E (37.3%), anti-c + E (9.5%), anti-C + e (3.3%) and anti-Jk (3.1%) were significantly more frequent.
作为一项东亚国际研究,我们通过性别以及输血或妊娠史评估红细胞同种异体免疫。共分析了超过 1826000 名患者的数据,其中 22653 例患者检出 26170 种不规则红细胞抗体。这些病例中的抗体频率如下:抗-E,26.8%;抗-Le,20.0%;抗-P1,7.1%;抗-M,6.4%;抗-Mi,5.6%;抗-c+E,5.6%;抗-Le,4.6%;抗-D,2.8%;抗-Fy,2.6%;抗-Le+Le,2.5%;抗-Di,2.0%;以及其他抗体。对于妊娠患者,抗-D(12.7%)的检出率更高。对于输血患者,抗-E(37.3%)、抗-c+E(9.5%)、抗-C+e(3.3%)和抗-Jk(3.1%)的检出率明显更高。